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Abstract 
Ethnopharmacological relevance 
Meadowsweet (Filipendula ulmaria (L.) Maxim.) and dropwort (Filipendula vulgaris Moench) 
are herbaceous perennials employed in folk medicine for their antirheumatic, antipyretic and 
anti-ulcer properties.  
Aim of the study 
To assess ethnomedicinal claims through investigation of antioxidant, anti-inflammatory and 
gastroprotective effects of F. ulmaria and F. vulgaris lyophilized flower infusions (LFIs) as well 
as the F. vulgaris isolated flavonoids spiraeoside, kaempferol 4-O-glucoside, astragalin 2-O-
gallate, mixture of hyperoside 2-O-gallate and isoquercitrin 2-O-gallate, and a tannin 
tellimagrandin II.  
Materials and methods 
Free radical scavenging activity of the tested samples was determined by examining their ability 
to neutralize DPPH and OH radicals in vitro, whereas reducing properties were assessed in Ferric 
Reducing Antioxidant Power (FRAP) assay. Anti-inflammatory activity was studied ex vivo in 
human platelets by monitoring the effect on eicosanoid biosynthesis. Gastroprotective action was 
estimated in animal model of acute gastric injury induced by ethanol.  
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Results 
 LFIs and spiraeoside exerted activities comparable to those of positive control in DPPH-radical 
scavenging and FRAP antioxidant assays, whereas notable hydroxyl radical scavenging ability 
was demonstrated only for spiraeoside (IC50 =5.1 μg/mL). Among tested samples, astragalin 
2″-O-gallate (IC50 =141.1 μg/mL) and spiraeoside (IC50 =4.69 μg/mL) the most markedly 
inhibited production of pro-inflammatory prostaglandin E2 and 12(S)-hydroxy-(5Z,8Z,10E,14Z)-
eicosatetraenoic acid in human platelets, respectively. Examination of LFIs (100–300 mg/kg, 
p.o.) gastroprotective action in rats revealed their capacity to preserve mucosal integrity. In 
addition, spiraeoside (50 mg/kg, p.o.) and tellimagrandin II (40 mg/kg, p.o.) showed ulcer 
preventive ability.  
Conclusion 
 Current study supports documented traditional use of investigated herbs and indicates that 
flavonoid and tannin components are partially responsible for the demonstrated pharmacological 
activities.  
Graphical abstract 
 
 
Keywords: Filipendula, meadowsweet, dropwort, antioxidant, anti-inflammatory, 
gastroprotective. 
 
1. Introduction 
3 
 
Meadowsweet (Filipendula ulmaria (L.) Maxim., syn. Spiraea ulmaria L.; Rosaceae) and 
dropwort (Filipendula vulgaris Moench, syn. Filipendula hexapetala Gilib.; Rosaceae) are 
herbaceous perennial plants which can be found in Europe (Ball, 1968). Their flowers are 
employed in traditional medicine with reputed beneficial effects in various ailments, such as 
rheumatism, gout, common cold, fever, infections and peptic ulcer disease (HMPC, 2011a; Jarić 
et al., 2007; Šarić-Kundalić et al., 2011; Vogl et al., 2013). European Medicines Agency 
approved use of meadowsweet flowers, Filipendulae ulmariae flos, for preparation of the 
traditional herbal medicinal products (HMPC, 2011b). 
Previous animal studies revealed that Filipendula species counteracted inflammatory 
processes and reduced pain (Katanić et al., 2016; Samardžić et al., 2016). A limited number of 
mechanistic in vitro experiments indicated that Filipendula extracts inhibited the classical 
pathway of the complement system (ESCOP, 2003), production of pro-inflammatory cytokines 
(Drummond et al., 2013) and expression of adhesion molecules (Vogl et al., 2013). 
Gastroprotection was to some extent explored earlier in meadowsweet (ESCOP, 2003), whereas 
respective data concerning dropwort are not available. However, scientific basis for folkloric 
applications of Filipendula species in the treatment of inflammatory conditions and peptic ulcer 
is not firmly established and additional investigations could considerably contribute to the 
estimation of reported use in traditional medicine. 
Phytochemical analysis showed that Filipendula species contain significant amount of 
polyphenolics, among which flavonol glycosides and ellagitannins are the most prominent 
(Olennikov and Kruglova, 2013). Despite the quite thorough characterization of the 
corresponding herbal drugs, the active constituents are not sufficiently defined and their role in 
the medicinal effects of meadowsweet and dropwort flowers is still not fully known. 
The current study was designed with the aim to provide scientific evidence that supports 
ethnomedicinal claims through the investigation of the relevant pharmacological properties of 
two Filipendula species and their active constituents. Anti-inflammatory activity of F. vulgaris 
isolated compounds and F. vulgaris and F. ulmaria lyophilized flower infusions (LFIs) was 
examined ex vivo in human platelets by monitoring the effects on eicosanoid production. 
Gastroprotective activity was tested using the ethanol-induced acute mucosal injury in rats and 
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antioxidant activity was investigated because free radicals scavenging and reducing properties 
may contribute to the tested biological effects. 
 
2. Materials and methods 
 
2.1. General 
All solvents used were of analytical grade, except those employed for high pressure liquid 
chromatography which were of HPLC or LC-MS quality. Reagents and substances required for 
chemical analysis of LFIs and pharmacological activities investigation were purchased from 
Sigma-Aldrich (Germany and USA), Carl Roth (Germany), Acros (Belgium), Fluka 
(Switzerland) and Zdravlje Actavis (Serbia). Spiraeoside, used for HPLC analysis, was isolated 
from Anthemis triumfetti (L.) DC. (Pavlović et al., 2006). Platelets concentrates were obtained 
from the Institute for Blood Transfusion of Vojvodina (Novi Sad, Serbia) immediately after 
expiry date for human use.  
Five flavonoids and one tannin were isolated from the F. vulgaris flowers by column 
chromatography (using silica gel and Sephadex LH-20 as adsorbents), C18 vacuum liquid 
chromatography, preparative TLC on cellulose-coated plates and RP-C18 semi-preparative 
HPLC. In order to elucidate their structures, UV, MS and NMR (
1
H and 
13
C) spectra were 
recorded. Detailed description of employed procedures and instruments is given in the 
Supplementary material. 
 
2.2. Plant material and preparation of lyophilized flower infusions 
Dropwort flowers were collected in May 2013 and 2014 near Loćika village (Central 
Serbia), whereas meadowsweet flowers were harvested at Mt. Kopaonik (Central Serbia) in July 
2016. Plant material was identified by Professor Branislava Lakušić (Department of Botany, 
University of Belgrade — Faculty of Pharmacy) and voucher specimens (F. vulgaris voucher 
number: 3713HFF; F. ulmaria voucher number: 3872HFF) were deposited in the Herbarium of 
the Department of Botany, University of Belgrade — Faculty of Pharmacy. 
Lyophilized flower infusions (LFIs) were obtained in accordance with traditional method 
of preparation. Namely, boiling water was poured over comminuted dried plant material (drug-
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solvent 1:20), the mixture was allowed to steep for 30 minutes with occasional stirring and 
filtered. The resulting extracts were freeze-dried. LFIs were obtained as fine powders with 
31.22% and 23.80% yield, for F. vulgaris and F. ulmaria, respectively.  
 
2.3. HPLC analysis of F. vulgaris and F. ulmaria lyophilized flower infusions 
Analyses of LFIs were performed on an Agilent 1100 Liquid chromatograph coupled to a 
DAD detector and equipped with Zorbax Eclipse XDB-C18 analytical column (4.6×250 mm, 5 
μm, Agilent). The aqueous solutions of LFIs were filtered through a 0.45 µm membrane filter 
and manually injected (20 µL). Separation was achieved at 25 °C by using a mixture consisting 
of solvent A (H3PO4 in H2O, pH 2.75) and solvent B (solvent A : acetonitrile, 10 : 90 v/v). 
Gradient composition of the binary mobile phase is presented in Table 1S (Supplementary 
material). LFIs constituents were identified by matching their retention times and UV spectra 
with the data of standards obtained under the same chromatographic conditions. Contents of 
detected substances were determined from calibration curves of gallic acid (y=202385x-293.76, 
R
2
=0.9992, concentration range 0.008– 0.131 mg/mL), salicylic acid (y=318761x+84.572, 
R
2
=0.9999, 0.002–0.066 mg/mL), hyperoside (y=23450x-20.696, R2=0.9993, 0.006–0.090 
mg/mL), astragalin (y=39970x, R
2
=0.9999, 0.009–0.140 mg/mL), isoquercitrin (y=19482x-
10.686, R
2
=1, 0.01–0.66 mg/mL), spiraeoside (y=13213x+45.692, R2=0.9979, 0.015–0.240 
mg/mL) and ellagic acid (y=14063x+62.467, R
2
=0.999, 0.008–0.130 mg/mL). For the purpose of 
quantification, detection was set at 210 nm for gallic acid and salicylic acid and at 350 nm for 
other compounds. 
 
2.4. Antioxidant assays 
In vitro antioxidant activity of spiraeoside and LFIs was determined using 
spectrophotometric methods as previously described (Kukić et al., 2006). Briefly, DPPH (2,2-
diphenyl-1-picrylhydrazyl) and 2-deoxyribose assays were used to estimate free radical 
scavenging capacity of the tested samples. Results are expressed as IC50, i.e. concentration of 
extract or compound causing 50% of DPPH or hydroxyl radical neutralization, respectively, and 
they were determined by regression analysis. FRAP (Ferric Reducing Antioxidant Power) assay, 
which is based on the ability of a sample to convert Fe
3+
-2,4,6-tris-(2-pyridyl)-s-triazine (Fe
3+
-
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TPTZ) to Fe
2+
-TPTZ complex, was applied to examine reducing properties. Results are 
expressed as FRAP value, i.e. mmol/g Fe
2+
 in the tested extract or compound.      
 
2.5. Inhibition of eicosanoid biosynthesis 
Anti-inflammatory activity of isolated flavonoids and LFIs was studied ex vivo in human 
platelets by monitoring the inhibition of synthesis of pro-inflammatory mediators prostaglandin 
E2 (PGE2), thromboxane B2 (TXB2) and 12(S)-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoic acid 
(12-HETE) (Lesjak et al., 2013). The formation of mediators was induced by addition of calcium 
ionophore A23187 and their concentrations were measured by LC-MS/MS. Inhibition of 
mediator production, I(%), was calculated according to the equation: I(%)=100×(R0-R)/R0. 
Response ratios (metabolite peak area/internal standard peak area) in the control reaction and 
tested samples were designated R0 and R, respectively. The results were expressed as IC50 values 
(obtained in Origin software, version 8.0), i.e. concentration of extract or compound leading to 
50% inhibition of mediator synthesis. 
 
2.6. Gastroprotective activity 
Investigation was conducted on male Wistar rats (6–8 weeks old; average weight 220 g) 
obtained from Military Academy Breeding Farm, Belgrade, Serbia. After delivery to our 
laboratory, animals were allowed to acclimatize for two weeks. Twenty hours before the start of 
the experiment, rats were fasted; meanwhile they had free access to tap water. Gastric lesions 
were induced by oral gavage of absolute ethanol (5 mL/kg, p.o.). Tested F. ulmaria and F. 
vulgaris LFIs (100–300 mg/kg, p.o.) and isolated compounds spiraeoside (50 mg/kg, p.o.) and 
tellimagrandin II (40 mg/kg, p.o.), were administered an hour before inducing the lesions. 
Animals from positive and negative control groups received ranitidine (20 mg/kg, p.o.) or 
vehicle (water, 1 mL/kg, p.o.), respectively. One hour after the treatment with absolute ethanol, 
animals were euthanized in atmosphere with high carbon dioxide content. Next, their stomachs 
were removed, opened along greater curvature and rinsed with saline solution. Lesions were 
examined under a magnifying glass (3×). Damage to mucosa was expressed as gastric damage 
score by using modified scoring system of Adami et al.: 0, no lesions; 0.5, slight hyperaemia or 
≤5 petechiae; 1, ≤5 erosions ≤5 mm length; 1.5, ≤5 erosions ≤5 mm length and many petechiae; 
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2, 6–10 erosions ≤5 mm length; 2.5, 1–5 erosions >5 mm length; 3, >5–10 erosions >5 mm 
length; 3.5, >10 erosions >5 mm length; 4, 1–3 erosions ≤5 mm length and 0.5–1 mm width; 4.5, 
4–5 erosions ≤5 mm length and 0.5–1 mm width; 5, 1–3 erosions >5 mm length and 0.5–1 mm 
width; 6, 4–5 grade 5 lesions; 7, ≥6 grade 5 lesions; 8, complete lesion of the mucosa with 
hemorrhage. Presence of statistically significant differences (
*
, p<0.05; 
**
, p<0.01) between test 
and control animal groups was estimated using Mann-Whitney U-test in SPSS software version 
20.0 (Đorđević et al., 2012). Experiment was approved by the Institutional Animal Care and Use 
Committee of the University of Belgrade — Faculty of Pharmacy (the bioethical allowance 
number: 323-07-1193/2014-05). All procedures were in accordance with the Directive 
2010/63/EU of the European Parliament and of the Council of Europe. 
 
3. Results and discussion 
 
3.1. Structure elucidation of the F. vulgaris flowers isolated compounds  
Processes of isolation, purification and structure elucidation led to the identification of five 
flavonol glycosides (1–5) and one ellagitannin (6) of the F. vulgaris flowers. UV and NMR (1H, 
13
C) spectra of the isolated compounds were in agreement with previous reports (Supplementary 
material) and MS data corresponded to the determined structures. Based on literature, compound 
1 was identified as kaempferol 4′-O-β-D-glucoside; 2 as spiraeoside (quercetin 4′-O-β-D-
glucoside); 3 as kaempferol 3-O-(2″-O-galloyl)-β-D-glucoside (astragalin 2″-O-gallate); mixture 
of 4 and 5 was identified as mixture of quercetin 3-O-(2″-O-galloyl)-β-D-glucoside (isoquercitrin 
2″-O-gallate) and quercetin 3-O-(2″-O-galloyl)-β-D-galactoside (hyperoside 2″-O-gallate) (2:1 
w/w, based on HPLC-UV chromatograms and NMR spectra integration), respectively; and 
finally, 6 was identified as tellimagrandin II (1,2,3-trigalloyl-4,6-hexahydroxydiphenoyl-β-D-
glucopyranose). Presence of these constituents, with the exception of kaempferol 3-O-(2″-O-
galloyl)-β-D-glucoside and quercetin 3-O-(2″-O-galloyl)-β-D-glucoside, was demonstrated 
earlier in F. vulgaris (Olennikov and Kruglova, 2013; Pukalskienė et al., 2015). A recent mass 
spectral analysis of dropwort extract showed presence of kaempferol O-galloyl-hexoside, 
consistent with our results (Pukalskienė et al., 2015). 
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Compounds 1, 2 and 3 and mixture 4+5 were tested for their anti-inflammatory activity, 
whereas the gastroprotective effects were investigated for the compounds 2 and 6. The 
antioxidant activity of compound 2 was also assayed. 
 
3.2. Composition of lyophilized flower infusions determined by HPLC 
HPLC analysis of LFIs revealed the presence of flavonol glycosides, phenolic acids and 
tannin (Table 1). Both LFIs contained glycosides of quercetin and kaempferol, but with certain 
differences in the composition. The dominant flavonoid constituent in both samples was 
spiraeoside (55.67±1.82 and 46.17±1.67 mg/g in F. vulgaris and F. ulmaria LFIs, respectively). 
In addition, the presence of isoquercitrin, hyperoside, astragalin, isoquercitrin 2″-O-gallate, 
hyperoside 2″-O-gallate, astragalin 2″-O-gallate and kaempferol 4′-O-β-D-glucoside was 
unambiguously confirmed in F. vulgaris LFI. Beside the dominant spiraeoside, meadowsweet 
LFI contained miquelianin (quercetin 3-O-β-D-glucuronide), kaempferol 4′-O-β-D-glucoside and 
a kaempferol glycoside. However, in contrast to dropwort LFI, hyperoside, isoquercitrin, 
astragalin and their respective 2″-O-galloylated derivatives were not detected in the meadowseet 
LFI. 
Regarding phenolic acids, both LFIs contained gallic acid as the most abundant, 
10.22±0.28 mg/g of dropwort LFI, 11.15±0.13 mg/g of meadowsweet LFI. Salicylic acid was 
present in lower amounts in both samples, whereas ellagic acid was detected only in dropwort 
LFI. 
Tellimagrandin II, a hydrolysable tannin, occurred in substantial amounts in investigated 
extracts of dropwort (15.80±0.46 mg/g) and meadowsweet (11.48±0.13 mg/g).  
Our results correspond relatively well with the recent studies of F. vulgaris and F. ulmaria 
flowers constituents (Bączek et al., 2012; Gniewosz et al., 2014; Olennikov and Kruglova, 
2013). 
 
Table 1. Composition of F. ulmaria and F. vulgaris lyophilized flower infusions (LFIs). 
Compound Content (mg/g) 
 F. ulmaria LFI F. vulgaris LFI 
Flavonol glycosides   
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Spiraeoside 46.17±1.67 55.67±1.82 
Hyperoside nd 5.12±0.17 
Hyperoside 2″-O-gallate nd 3.8±0.1a 
Isoquercitrin nd 13.24±0.33 
Isoquercitrin 2″-O-gallate nd 6.3±0.19b 
Miquelianin 26.95±0.27
b
 nd 
Astragalin nd 11.22±0.35 
Astragalin 2″-O-gallate nd 4.58±0.01c 
Kaempferol 4′-O-β-D-glucoside 8.27±0.12c 4.91±0.03c 
Kaempferol glycoside 7.37±0.33
c
 nd 
   
Phenolic acids   
Gallic acid 11.15±0.13 10.22±0.28 
Ellagic acid nd 3.8±0.18 
Salicylic acid 1.55±0.03 3.5±0.12 
   
Tannin   
Tellimagrandin II 11.48±0.13
d
 15.80±0.46
d
 
Data are presented as means±SD, n=3; nd, not detected; 
a
 calculated as hyperoside; 
b
 calculated 
as isoquercitrin; 
c
 calculated as astragalin; 
d
 calculated as gallic acid. 
 
3.3. Antioxidant activity 
 
In DPPH and FRAP assays, LFIs and their quantitatively dominant flavonoid glycoside 
spiraeoside displayed significant antioxidant properties comparable to those of the control 
substance (Table 2). Spiraeoside surprisingly exhibited lower potency than LFIs in the DPPH 
assay, possibly due to the lack of a key structural feature (o-dihydroxy system) generally 
required for high flavonoid antiradical effectiveness (Yokozawa et al., 1998). 
On the other hand, hydroxyl radical scavenging of LFIs, determined by 2-deoxyribose 
assay, did not reach 50% inhibition. However, spiraeoside was active (IC50=5.1 μg/mL). 
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Table 2. Antioxidant activity of lyophilized flower infusions (LFIs) and spiraeoside. 
  
DPPH IC50
a
 
(μg/mL) 
•
OH IC50
b
  
(μg/mL) 
FRAP value
a
  
(mmol Fe
2+
/g) 
F. vulgaris LFI 9.10±0.09 ne 7.72±0.04 
F. ulmaria LFI 8.45±0.06 ne 4.46±0.1 
Spiraeoside 19.54±0.23 5.1 15.02±0.64 
L-ascorbic acid 4.09
c
 nt 13.29±0.26 
Quercetin nt 3.1
c
 nt 
nt, not tested; ne, not effective – IC50>16.67 μg/mL; 
a
 expressed as mean±SD (n=3); 
b
 data from 
three independent experiments; 
c
 Kukić et al., 2006. 
 
Demonstrated good anti-DPPH and Fe
3+
 reducing properties of LFIs are in agreement with 
previously published reports on different types of Filipendula extracts (Maksimović et al., 2007; 
Olennikov et al., 2016). Based on the results of HPLC analysis (Table 1), it could be assumed 
that LFIs considerable antioxidant capacity is related to their high content of polyphenolic 
compounds. Moreover, it seems likely that spiraeoside participates in the LFIs total antioxidant 
effect. Antioxidants could assist in attenuation of inflammatory response and in prevention of 
gastric ulceration (Đorđević et al., 2012), so the data obtained in our experiment are of relevance 
for the investigated medicinal plants. 
 
3.4. Inhibition of eicosanoid biosynthesis ex vivo 
In this study, hypothesis that diminished eicosanoid formation is involved in anti-
inflammatory effect of flowers of investigated Filipendula species was checked using stimulated 
human platelets as an ex vivo model system. After their exposure to LFIs or F. vulgaris isolated 
compounds, the concentrations of generated eicosanoids (PGE2, TXB2 and 12-HETE) were 
measured. Most of the tested samples, i.e. LFIs and isolated flavonoids, in the applied 
concentration ranges (0.25–10 mg/mL for LFIs; 0.4–200 μg/mL for kaempferol 4′-O-β-D-
glucoside, astragalin 2″-O-gallate and mixture of isoquercitrin 2″-O-gallate and hyperoside 2″-O-
gallate; 2–160 μg/mL for spiraeoside) were able to decrease the levels of monitored metabolites 
(Table 3). 
11 
 
IC50 values were in the range of 0.961–4.401 mg/mL and 3.415–6.768 mg/mL for dropwort 
and meadowsweet LFIs, respectively, and were higher than the corresponding values of control 
substances (acetylsalicylic acid and quercetin). F. vulgaris LFI more effectively inhibited 
production of all monitored mediators compared to F. ulmaria LFI. Investigated extracts 
exhibited the greatest potency in attenuation of 12-HETE synthesis, weaker activity was 
observed for reduction of PGE2 level, whereas only F. vulgaris LFI was able to reach more than 
50% inhibition of TXB2 generation. 
Capacity of isolated flavonoids to affect concentration of eicosanoids varied considerably. 
Tested compounds did not reach 50% suppression of TXB2 formation. Regarding inhibition of 
PGE2 production, astragalin 2″-O-gallate was the most effective among examined compounds 
(IC50=141.1 μg/mL). Mixture of hyperoside 2″-O-gallate and isoquercitrin 2″-O-gallate (1:2), as 
well as spiraeoside, decreased PGE2 levels by more than 50%, but the effect was not 
concentration-dependent. Spiraeoside inhibited production of 12-HETE with notable potency 
(IC50=4.69 μg/mL) comparable to that of quercetin (IC50=7.44 μg/mL). Astragalin 2″-O-gallate 
and mixture of hyperoside 2″-O-gallate and isoquercitrin 2″-O-gallate were less active with IC50 
values of 90.21 and 121.8 μg/mL, respectively. It appears that glycosylation of quercetin 
hydroxyl group at the position 4′ does not diminish potential to inhibit 12-HETE production. On 
the other hand, galloylated glycosyl groups at the position 3 of aglycone and/or lack of hydroxyl 
group at the position 3′ seems to be unfavorable. Kaempferol 4′-O-β-D-glucoside displayed no 
activity in the tested concentration range.  
 
Table 3. Inhibition of eicosanoid production by lyophilized flower infusions (LFIs) and F. 
vulgaris isolated compounds. 
 12-HETE PGE2 TXB2 
 IC50 (μg/mL) 
LFIs    
F. vulgaris LFI 961±83 4241±67 4401±62 
F. ulmaria LFI 3415±294  6768±108 ne 
    
F. vulgaris isolated compounds    
Kaempferol 4′-O-β-D-glucoside na na na 
Spiraeoside 4.69±0.4  ncd ne 
Astragalin 2″-O-gallate 90.21±7.76 141.1±2.24 ne 
12 
 
Mixture of hyperoside 2″-O-gallate  
and isoquercitrin 2″-O-gallate (1:2 w/w) 
121.8±10.47 ncd ne 
Control substances    
Acetylsalicylic acid na 5.58±0.53
a
 4.98±0.06
a
 
Quercetin 7.44±0.65
a
 12.75±0.26
a
 53.69±2.47
a
 
    
Results are expressed as means±SD (n=3); nt, not tested; na, not active — did not exhibit any activity; ne, not 
effective — did not reach 50 % inhibition; ncd, inhibition above 50% but not concentration dependent; a Lesjak et 
al., 2013. 
 
Elevated eicosanoids production often accompanies inflammatory processes and 
suppression of their biosynthesis represents a clinically useful therapeutic approach. They are 
derived by enzymatically catalyzed transformation of arachidonic acid. PGE2 plays many 
important roles in human organism, however, its vasodilating, hyperalgesic and pyrogenic 
properties are the most relevant for the current study (Rang et al., 2012). 12-HETE was identified 
as a neutrophil chemotaxin. In addition, involvement of this eicosanoid in different conditions 
(i.e. cancer and hypertension) is increasingly recognized (Porro et al., 2014). Thromboxane A2 
(TXA2) exerts procoagulatory and proinflammatory actions (Rang et al., 2012; Semple et al., 
2011). The effect of studied samples on TXA2 biosynthesis was monitored indirectly, through 
the measurement of the concentration of its inactive metabolite (TXB2). Direct determination of 
TXA2 is not suitable as it rapidly and spontaneously converts to TXB2 (Rang et al., 2012). 
Taking into account the abovementioned facts and our results, it could be assumed that 
examined compounds contribute to the medicinal action of the Filipendula flowers. In that 
regard, current finding that spiraeoside, astragalin 2″-O-gallate and tested mixture of galloylated 
flavonoids attenuated synthesis of PGE2 may be important to explain traditional use for 
alleviation of inflammatory and painful conditions. High potential of spiraeoside to suppress 12-
HETE production represents considerable therapeutic potential and requires more detailed 
investigation. The observed low effectiveness of LFIs and isolated flavonoids in the inhibition of 
TXB2 formation may indicate that studied samples do not modulate inflammation and 
coagulation processes mediated by TXA2. In vivo studies are required to determine whether the 
pharmacokinetic fate influences the demonstrated activities of the tested flavonoids.  
LFIs were characterized by high polyphenol content (Table 1) and prominent antioxidant 
properties (Table 2). Therefore, their mode of action may be based in part on neutralizing free 
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radicals, which are important mediators in the eicosanoid biosynthetic pathways (Schneider et 
al., 2007). Isolated compounds may also act in similar manner due to generally good scavenging 
ability of polyphenols (Lesjak et al., 2013).  
Gallic and salicylic acid, that are also present in the LFIs (Table 1), were reported to inhibit 
COX-1 (one of key enzymes responsible for prostaglandins generation) (Chandramohan Reddy 
et al., 2010; Grosser et al., 2011). In addition to tested compounds, they may contribute to the 
LFIs effect on PGE2 production. Hence, it seems that several different active constituents 
contribute to the beneficial anti-inflammatory effect of investigated LFIs. 
In previous in vitro studies, which were carried out by using isolated cyclooxygenase 
enzymes or bovine seminal vesicle microsomes, several extracts of F. ulmaria inhibited PGE2 
biosynthesis (ESCOP, 2003; Katanić et al., 2016). Investigation of F. vulgaris effect on 12-
HETE, TXA2 and PGE2 formation has not been conducted so far. Pain relieving and 
antiedematous properties of certain meadowsweet and dropwort extracts (Katanić et al., 2016; 
Samardžić et al., 2016) were demonstrated in animal studies, nevertheless, their mechanism of 
action and active constituents are still not sufficiently defined. Moreover, data regarding the 
traditionally used preparations lack.  
The present experiment was carried out on the intact cells, enabling better prediction of the 
in vivo action when compared with the tests performed on the isolated enzymes or subcellular 
structures. More complete picture of the anti-inflammatory effect of tested samples was obtained, 
by detecting their influence on 12-HETE and TXA2 in addition to PGE2. The present study 
revealed the significant anti-inflammatory activity of flower infusions, preparation relevant for 
the reported ethnopharmacological application (HMPC, 2011b). Moreover, for the first time it 
was shown that flavonoids from Filipendula LFIs represented the active principles responsible 
for the suppression of the eicosanoids production. 
 
3.5. Gastroprotective activity 
F. vulgaris and F. ulmaria LFIs gastroprotective effects were demonstrated for all tested 
doses (p<0.05), with the exception of the lowest dose of F. vulgairs LFI (100 mg/kg) (Table 4). 
Average gastric damage scores (GDSs) in animal groups treated with dropwort and 
meadowsweet LFIs were in the range of 3.4–4 and 1.4–2.9, respectively. Although GDSs of LFIs 
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were the most reduced in animal groups receiving the highest quantities of the examined extracts 
(300 mg/kg), statistically significant dose-response relationship was not observed. Oral 
administration of isolated compounds, spiraeoside (50 mg/kg, GDS 3.6, p<0.05) and 
tellimagrandin II (40 mg/kg, GDS 3.7, p<0.05), also decreased severity of the formed lesions in 
the present animal study. Ranitidine, as a positive control, evidently protected gastric mucosa 
(GDS 2.5, p<0.01), whereas control group of animals which received vehicle (water) developed 
the most extensive damage of stomach mucosa (GDS 6). 
 
Table 4. Average gastric damage scores (GDSs) in animal groups treated with lyophilized flower 
infusions (LFIs), isolated compounds, referent drug or vehicle. 
 GDS 
Lyophilized flower infusions  
F. vulgaris   100 mg/kg 3.92±2.5 
 200 mg/kg 4±1.76
*
 
 300 mg/kg 3.42±2.11
*
 
F. ulmaria   100 mg/kg 2.6±2.38
*
 
 200 mg/kg 2.9±1.95
*
 
 300 mg/kg 1.4±2.01
*
 
   
F. vulgaris isolated compounds  
Tellimagrandin II 40 mg/kg 3.67±2.04
*
 
Spiraeoside 50 mg/kg 3.58±2.2
*
 
  
Referent drug  
Ranitidine 20 mg/kg 2.5±1.87
**
 
  
Control   
Vehicle (water)
a
 6±1.26 
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Data are presented as means±SD (n=5–6); *, statistically significant versus control group for 
p˂ 0.05, and **, statistically significant versus control group for p˂ 0.01; a applied in the same 
volume as tested samples (1 mL/kg). 
 
To the best of our knowledge, this is the first report of dropwort capability to prevent 
ethanol-induced mucosal injury. Established activity of LFI is in accordance with the literature 
data regarding meadowsweet preparations. Specifically, it was shown that F. ulmaria flowers 
decoctions were effective in some animal models of stomach ulcerations (ESCOP, 2003).  
Demonstrated protective activity of isolated tannin tellimagrandin II is supported by the 
fact that molecules with relative structural resemblance applied in similar doses (pedunculagin, 
50 mg/kg, i.g.; corilagin, 30 mg/kg, p.o.) exerted activity in the mice treated with the same 
harmful agent as in the current experiment (de Jesus et al., 2012; Klein-Júnior et al., 2017). 
Spiraeoside effectiveness is in line with previously observed capacity of some flavonoid 
glycosides to prevent stomach injury in animals (de Lira Mota et al., 2009). 
Free radical species are involved in the onset of the mucosal damage evoked by necrotizing 
agent ethanol (Đorđević et al., 2012). Hence, pronounced antioxidant activity of tested LFIs and 
isolated compounds (Table 2) (Chen et al., 2014) probably contributed to the preservation of the 
stomach mucosal integrity. Furthermore, attenuation of lesions formation achieved by 
tellimagrandin II could be related to the recently demonstrated histidine decarboxylase inhibition 
in vitro (Nitta et al., 2013). 
Our data strongly suggest that LFIs beneficial effects are associated with the presence of 
spiraeoside and tellimagrandin II, but role of other LFIs components should also be investigated 
in the future studies. 
 
4. Conclusion 
Lyophilized flower infusions of F. vulgaris and F. ulmaria were rich in polyphenolics that 
belong to the classes of flavonol glycosides, phenolic acids and hydrolysable tannins. These 
preparations, as well as the F. vulgaris flowers flavonoids (spiraeoside, astragalin 2″-O-gallate 
and mixture of hyperoside 2″-O-gallate and isoquercitrin 2″-O-gallate), were able to decrease 
production of proinflammatory eicosanoids ex vivo in human platelets. The investigated extracts, 
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along with spiraeoside and tellimagrandine II, also protected stomach mucosa of the rats from 
toxic effects induced by absolute ethanol. 
The results obtained in this study support reported traditional use of meadowsweet and 
dropwort flowers in the treatment of inflammatory conditions and peptic ulcer and indicate that 
examined flavonoid and tannin compounds are pharmacologically active constituents.  
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